Matthew Petroski, Ph.D. (Sanford-Burnham Institute for Medical Research) received a V Scholar Grant from The V Foundation in 2008. Petroski recently helped discover a cell mutation that prevents the drug MLN4924 from successfully killing cancer cells. By establishing the particular mutation that causes cell immunity to MLN4924, researchers might be able to develop more personalized cancer therapies for patients.
Petroski co-authored a report on his findings which detailed why the research is so important to cancer research. He said these new therapy techniques are already being used in numerous clinical trials focused on cancers such as myeloma, leukemia and lymphoma.